Novel phosphorylations of IKKγ/NEMO

mBio

Volumn 3, Issue 6, 2012, Pages

  Lee, Sun Hwa ^a   Toth, Zsolt ^a   Wong, Lai Yee ^a   Brulois, Kevin ^a   Nguyen, Jim ^a   Lee, June Yong ^a   Zandi, Ebrahim ^a   Jung, Jae U ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLICE INHIBITORY PROTEIN; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROTEIN KINASE FGR; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MASS SPECTROMETRY; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

HUMAN HERPESVIRUS 8;

EID: 84872124759     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00411-12     Document Type: Article

References (48)

1. Häcker H, Karin M. 2006. Regulation and function of IKK and IKKrelated kinases. Sci. STKE 2006:re13. http://dx.doi.org/10.1126/stke.3572006re13.
2. Vallabhapurapu S, Karin M. 2009. Regulation and function of NFkappaB transcription factors in the immune system. Annu. Rev. Immunol. 27:693-733.
3. Israël A. 2010. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harbor Perspect. Biol. 2:a000158. http://dx.doi.org/10.1101/cshperspect.a000158.
4. Ruland J. 2011. Return to homeostasis: downregulation of NF-kappaB responses. Nat. Immunol. 12:709-714.
5. Baldwin AS, Jr. 2001. Series introduction: the transcription factor NFkappaB and human disease. J. Clin. Invest. 107:3-6.
6. Sebban H, Yamaoka S, Courtois G. 2006. Posttranslational modifications ofNEMOand its partners in NF-kappaB signaling. Trends Cell Biol. 16:569-577.
7. Perkins ND. 2006. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717-6730.
8. Zheng C, Yin Q, Wu H. 2011. Structural studies of NF-kappaB signaling. Cell Res. 21:183-195.
9. Zhou H, et al. 2004. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427:167-171.
10. Yamamoto M, et al. 2006. Key function for the Ubc13 E2 ubiquitinconjugating enzyme in immune receptor signaling. Nat. Immunol. 7:962-970.
11. Tang ED, Wang CY, Xiong Y, Guan KL. 2003. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J. Biol. Chem. 278:37297-37305.
12. Abbott DW, Wilkins A, Asara JM, Cantley LC. 2004. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14:2217-2227.
13. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. 2006. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311:1141-1146.
14. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. 2003. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115:565-576.
15. Bergink S, Jentsch S. 2009. Principles of ubiquitin and Sumo modifications in DNA repair. Nature 458:461-467.
16. Tarassishin L, Horwitz MS. 2001. Sites on FIP-3 (NEMO/IKKgamma) essential for its phosphorylation and NF-kappaB modulating activity. Biochem. Biophys. Res. Commun. 285:555-560.
17. Prajapati S, Gaynor RB. 2002. Regulation of Ikappa B kinase (IKK-)gamma /NEMO function by IKKbeta-mediated phosphorylation. J. Biol. Chem. 277:24331-24339.
18. Carter RS, Pennington KN, Ungurait BJ, Ballard DW. 2003. In vivo identification of inducible phosphoacceptors in the IKKgamma/NEMO subunit of human IkappaB kinase. J. Biol. Chem. 278:19642-19648.
19. Wang C, et al. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-351.
20. Senftleben U, et al. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495-1499.
21. Ling L, Cao Z, Goeddel DV. 1998. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of ser-176. Proc. Natl. Acad. Sci. U. S. A. 95:3792-3797.
22. Delhase M, Hayakawa M, Chen Y, Karin M. 1999. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284:309-313.
23. Hiscott J, Nguyen TL, Arguello M, Nakhaei P, Paz S. 2006. Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 25:6844-6867.
24. Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120:939-949.
25. Thome M, et al. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521.
26. Hu S, Vincenz C, Buller M, Dixit VM. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272: 9621-9624.
27. Bertin J, et al. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94:1172-1176.
28. Sun Q, Zachariah S, Chaudhary PM. 2003. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J. Biol. Chem. 278:52437-52445.
29. Liu L, et al. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J. Biol. Chem. 277:13745-13751.
30. Field N, et al. 2003. KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell Sci. 116:3721-3728.
31. Chaudhary PM, Jasmin A, Eby MT, Hood L. 1999. Modulation of the NF-kappa B pathway by virally encoded death effector domainscontaining proteins. Oncogene 18:5738-5746.
32. Oppermann FS, et al. 2009. Large-scale proteomics analysis of the human kinome. Mol. Cell. Proteomics 8:1751-1764.
33. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. 1997. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91:243-252.
34. Rothwarf DM, Zandi E, Natoli G, Karin M. 1998. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395: 297-300.
35. Rushe M, et al. 2008. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure 16:798-808.
36. May MJ, et al. 2000. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289:1550-1554.
37. Tegethoff S, Behlke J, Scheidereit C. 2003. Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation. Mol. Cell. Biol. 23:2029-2041.
38. Agou F, et al. 2002. NEMO trimerizes through its coiled-coil C-terminal domain. J. Biol. Chem. 277:17464-17475.
39. Dephoure N, et al. 2008. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 105:10762-10767.
40. Seo J, Lee KJ. 2004. Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J. Biochem. Mol. Biol. 37:35-44.
41. Xiao G, Sun SC. 2000. Activation of IKKalpha and IKKbeta through their fusion with HTLV-I tax protein. Oncogene 19:5198-5203.
42. Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT. 1999. Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I tax interacts directly with IkappaB kinase gamma. J. Biol. Chem. 274:17402-17405.
43. Matta H, Sun Q, Moses G, Chaudhary PM. 2003. Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory proteininduced NF-kappaB activation. J. Biol. Chem. 278:52406-52411.
44. Shifera AS. 2010. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB. J. Cell. Physiol. 223: 558-561.
45. Shifera AS. 2010. Proteins that bind to IKKgamma (NEMO) and downregulate the activation of NF-kappaB. Biochem. Biophys. Res. Commun. 396:585-589.
46. Matta H, Chaudhary PM. 2004. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domainlike IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc. Natl. Acad. Sci. U. S. A. 101:9399-9404.
47. Shimizu A, et al. 2011. Kaposi's sarcoma-associated herpesvirus vFLIP and human T cell lymphotropic virus type 1 tax oncogenic proteins activate IkappaB kinase subunit gamma by different mechanisms independent of the physiological cytokine-induced pathways. J. Virol. 85: 7444-7448.
48. Garcia MI, Kaserman J, Chung YH, Jung JU, Lee SH. 2007. Herpesvirus saimiri STP-A oncoprotein utilizes Src family protein tyrosine kinase and tumor necrosis factor receptor-associated factors to elicit cellular signal transduction. J. Virol. 81:2663-2674.